Sandra R. Reynolds - Concepedia

Author

Sandra R. Reynolds

New York University

Also Known As

Joseph Barry, S R Reynolds, S. R. Reynolds, S.R. Reynolds, Sandra R Reynolds, Sandra R. Reynolds, Sandra Reynolds

Publications

837

Citations

H-Index

Concepts

All Affiliations

New York University Roswell Park Comprehensive Cancer Center Massachusetts Department of Public Health Hunter College The Rogosin Institute

About

Sandra R. Reynolds is an author at New York University specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	158
2	Immunology	8	8	158
3	Health Sciences	1	1	15
4	Allergy	1	1	22
5	Cell Biology	1	1	19

Sandra R. Reynolds

Publications

686

Citations

H-Index

Page 1

	Year	Citations
T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni Sandra R. Reynolds, C.B. Shoemaker, Donald A. Harn The Journal of Immunology	1992	95
HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients Sandra R. Reynolds, Esteban Celis, Alessandro Sette, The Journal of Immunology	1998	87
T and B epitope determination and analysis of multiple antigenic peptides for the <i>Schistosoma mansoni</i> experimental vaccine triose-phosphate isomerase. Sandra R. Reynolds, Charles E. Dahl, Donald A. Harn The Journal of Immunology	1994	84
Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine Sandra R. Reynolds, Ruth Oratz, Richard L. Shapiro, International Journal of Cancer	1997	65
Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanoma. Sandra R. Reynolds, J.K. Albrecht, Richard L. Shapiro, PubMed	2003	59
Candidate vaccine antigens that stimulate the cellular immune response of mice vaccinated with irradiated cercariae of <i>Schistosoma mansoni</i>. D. Richter, Sandra R. Reynolds, Donald A. Harn The Journal of Immunology	1993	45
Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma. Sandra R. Reynolds, Anne Zeleniuch‐Jacquotte, Richard L. Shapiro, PubMed	2003	43
Presence and Prognostic Significance of Melanoma-Associated Antigens CYT-MAA and HMW-MAA in Serum of Patients with Melanoma Irene Vergilis, Michael Szarek, Soldano Ferrone, Journal of Investigative Dermatology MedicineMelanomaImmunologyPathologyPrognostic Significance	2005	36
Identification of HLA-A03, A11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis Sandra R. Reynolds, Esteban Celis, Alessandro Sette, Journal of Immunological Methods Cancer ImmunosurveillanceAutoimmune DiseaseImmunologyImmunodominancePathology	2000	27
Comparison of irradiated-cercaria schistosome vaccine models that use 15- and 50-kilorad doses: the 15-kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge Sandra R. Reynolds, Donald A. Harn Infection and Immunity Parasitic DiseaseVaccine ModelsImmunologyImmunotherapy50-Kilorad Doses	1992	22

Page 1